emphasizes the brain
健达九州
emphasizes the brain
Biotech/Healthcare
Jianda Jiuzhou has closed a Series A round of several hundred million RMB. The proceeds will fund clinical validation of its core pipeline and accelerate the development and commercialization of precision therapies for brain diseases.
Latest round: Series A (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-07-30
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.